Apolipoprotein A-I mimetic improves HDL anti-inflammatory function
Administration of the apolipoprotein A-I mimetic peptide D-4F improves
anti-inflammatory activity of HDL in patients at high risk of coronary
heart disease, suggesting therapeutic potential for attenuation of
atherosclerosis.